Business
Rapid testing no substitute to COVID vaccination: Cochlear boss – Sydney Morning Herald
The $17 billion hearing implants maker has returned to profit, with its boss focused on emerging from the pandemic with a stronger…
The $17 billion hearing implants maker posted record sales of $1.4 billion for the 12 months to June and managed to spring from its $238 million loss in 2020 to a $327 million net profit for 2021.
The profit exceeded expectations, but overall sales came…
Continue Reading
-
Noosa News17 hours agoCrucial step in Sea World helicopter crash investigation set
-
Business16 hours agoWhy Accent, DroneShield, EBR Systems, and Titomic shares are pushing higher
-
Noosa News23 hours agoLocal input into new UN treaty – Proctor
-
Business21 hours agoIs the Qantas share price a buy in the tariff ASX stock market volatility?